Short answer
ZEVRA THERAPEUTICS, INC. (ZVRA) filed an 8-K current report with the SEC on June 5, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 78.37% of outstanding shares voted at the June 4, 2026 annual meeting.
ZEVRA THERAPEUTICS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 78.37% of outstanding shares voted at the June 4, 2026 annual meeting
- Douglas W. Calder and Corey Watton elected as Class II directors through 2029
- Ernst & Young ratified as independent auditor with 45,947,281 votes for
- Board declassification failed, receiving 32,557,653 votes for versus a required 66⅔% of outstanding shares
- Classified board structure remains in place, limiting annual shareholder accountability for directors
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ZEVRA THERAPEUTICS, INC. 8-K filings
Get the next ZVRA 8-K as it lands
Follow ZVRA for push alerts, or ask the research agent what this filing means.